世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

血液・血漿成分市場 - 世界の産業規模、シェア、動向、機会、予測、2017-2027製品別(パック赤血球、血小板製品、凍結血漿、血漿由来製品)、用途別(血液学、固形腫瘍管理、その他)、エンドユーザー別(病院・クリニック、診断ラボ、その他)、企業別、地域別


Blood & Plasma Components Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027Segmented By Products (Packed Red Blood Cells, Platelets Products, Frozen Plasma, Plasma Derived Products), By Application (Hematology, Solid Tumor Management, Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Others), By company and By Region

世界の血液・血漿成分市場は、2023年から2027年の予測期間中に目覚ましい成長を遂げると予測されている。主な要因としては、手術件数の増加、外傷や交通事故の急増、癌を含む慢性疾患患者の増加が市場の成長を抑... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechSci Research
テックサイリサーチ
2023年8月1日 US$4,900
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
117 英語

 

サマリー

世界の血液・血漿成分市場は、2023年から2027年の予測期間中に目覚ましい成長を遂げると予測されている。主な要因としては、手術件数の増加、外傷や交通事故の急増、癌を含む慢性疾患患者の増加が市場の成長を抑制している。血液は生命を維持するための体液であり、全身を流れ、体組織に栄養、電解質、ホルモン、抗体、ビタミンを供給する。血漿は血液の一部で水性であり、塩分とタンパク質を含み、その中に血小板、白血球、赤血球が浮遊している。市場の成長を支えるその他の要因としては、献血の意義に関連する意識の高まり、患者数の多さ、政府の取り組み、研究開発活動への投資の増加、様々な血液団体によって実施される献血キャンペーン、高齢者人口の増加、研究開発活動の増加、技術の進歩などが挙げられる。また、市場プレーヤーが実施するパートナーシップや製品発売などの戦略的イニシアチブは、市場の成長を増強している。
外傷と交通事故の増加
外傷や交通事故の発生率の増加は、市場の成長を促進する重要な要因である。時として、人々は出血などの外傷に見舞われ、存在する血液の量が減少し、身体によって十分に速く補充されなくなる。レビューによると、2018年には毎年約6万人のアメリカ人が出血や失血で死亡している。また、交通事故の増加により、体内の血液が過剰に失われ、出血を防ぐために血液や血漿を輸血する需要が高まっている。このような状況が、血液・血漿成分市場の世界的な成長を増大させている。WHOの調査によると、2020年には世界中で毎年150万人近くが交通事故が原因で死亡している。
血液疾患と手術の頻度の増加
出血性疾患の増加や世界的な手術件数の増加が市場の成長を後押ししている。血友病AおよびB、von Willebrand病は最も一般的な出血性疾患である。例えば、2019年には世界中で195,263人が血友病と診断され、80,302人がvon Willebrand病と診断された。これらに加えて、手術中に多くの血液が失われ、輸血が必要になる可能性が高まるため、手術症例の増加が市場の成長を促している。また、貧血患者では輸血の需要が高まる。例えば、世界では毎年約3億1,000万件の大手術が行われており、そのうち5,000万件は米国で、2,000万件は欧州で行われている。
無機的成長戦略の採用増加
合併、提携、買収、パートナーシップなど、さまざまな無機的成長戦略が市場の成長を支えている。例えば、Blood Center of WisconsinはSysLogic Inc.と協業し、血液製剤の収集や輸血中にRFID技術を活用して患者の安全性を高める方法を研究した。同様に、2018年には、Invitrx Inc.が、神経新生と認知機能を高める抗老化効果が期待できる可塑性促進タンパク質を含む臍帯血漿製品を発売した。
市場区分
世界の血液・血漿成分市場は、製品、用途、エンドユーザー、企業に区分される。製品に基づくと、市場は充填赤血球、血小板製品、凍結血漿、血漿由来製品に分けられる。血漿由来製品に基づくと、市場はさらに免疫グロブリン、アルブミン、凝固因子濃縮物、その他に分けられる。用途別では、市場は血液学、固形腫瘍管理、その他に分けられる。血液学に基づくと、市場はさらにヘモグロビン血症、血液悪性腫瘍治療、凝固異常症、その他に分けられる。エンドユーザーに基づくと、市場は病院&クリニック、診断研究所、その他に分けられる。国別では、米国は慢性疾患や手術件数が増加しているため、予測期間中に有利な市場になると予想される。
市場プレイヤー
CSL Limited、Grifols S.A.、ADMA Biologics, Inc.、武田薬品工業株式会社、Octapharma AG、Kedrion S.p.A.、Emergent BioSolutions Inc.、Bio Products Laboratory Ltd.、LFB S.A.、Versiti, Inc.などが、この市場で事業を展開している大手企業である。
レポートの範囲
本レポートでは、世界の血液・血漿成分市場を以下のカテゴリーに分類し、さらに業界動向についても詳述しています:
- 血液・血漿成分市場、製品別
o 包装赤血球
o 血小板製品
o 凍結血漿
o 血漿由来製品
 免疫グロブリン
 アルブミン
 凝固因子濃縮製剤
 その他
- 血液・血漿成分市場、用途別
血液学
 ヘモグロビン血症
 血液悪性腫瘍治療
 凝固異常症
 その他
o 固形腫瘍管理
o その他
- 血液・血漿成分市場、エンドユーザー別
o 病院および診療所
o 診断研究所
o その他
- 血液・血漿成分市場:地域別
北米
 米国
 カナダ
 メキシコ
o アジア太平洋
 中国
 インド
 日本
 オーストラリア
 韓国
ヨーロッパ & CIS
 ドイツ
 フランス
 イギリス
 スペイン
 イタリア
o 南米
 ブラジル
 アルゼンチン
 コロンビア
o 中東・アフリカ
 南アフリカ
 サウジアラビア
 UAE
競争環境
企業プロフィール:世界の血液・血漿成分市場における主要企業の詳細分析
利用可能なカスタマイズ:
TechSci Research社は、与えられた市場データをもとに、企業固有のニーズに応じたカスタマイズを提供しています。本レポートでは以下のカスタマイズが可能です:
企業情報
- 追加市場参入企業(最大5社)の詳細分析とプロファイリング

ページTOPに戻る


目次

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Blood & Plasma Components Market
5. Voice of Customer
6. Global Blood & Plasma Components Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Products (Packed Red Blood Cells, Platelets Products, Frozen Plasma, Plasma Derived Products)
6.2.1.1. By Plasma Derived Products (Immunoglobulins, Albumins, Coagulation Factor Concentrates, Others)
6.2.2. By Application (Hematology, Solid Tumor Management, Others)
6.2.2.1. By Hematology (Hemoglobinopathy, Hematologic Malignancies Treatment, Coagulopathy, Others)
6.2.3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
6.2.4. By Company (2021)
6.2.5. By Region
6.3. Market Map
7. North America Blood & Plasma Components Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Products (Packed Red Blood Cells, Platelets Products, Frozen Plasma, Plasma Derived Products)
7.2.1.1. By Plasma Derived Products (Immunoglobulins, Albumins, Coagulation Factor Concentrates, Others)
7.2.2. By Application (Hematology, Solid Tumor Management, Others)
7.2.2.1. By Hematology (Hemoglobinopathy, Hematologic Malignancies Treatment, Coagulopathy, Others)
7.2.3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Blood & Plasma Components Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Products
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.2. Canada Blood & Plasma Components Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Products
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. Mexico Blood & Plasma Components Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Products
7.3.3.2.2. By Application
7.3.3.2.3. By End User
8. Europe Blood & Plasma Components Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Products (Packed Red Blood Cells, Platelets Products, Frozen Plasma, Plasma Derived Products)
8.2.1.1. By Plasma Derived Products (Immunoglobulins, Albumins, Coagulation Factor Concentrates, Others)
8.2.2. By Application (Hematology, Solid Tumor Management, Others)
8.2.2.1. By Hematology (Hemoglobinopathy, Hematologic Malignancies Treatment, Coagulopathy, Others)
8.2.3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. France Blood & Plasma Components Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Products
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. Germany Blood & Plasma Components Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Products
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. United Kingdom Blood & Plasma Components Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Products
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. Italy Blood & Plasma Components Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Products
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Spain Blood & Plasma Components Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Products
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. Asia-Pacific Blood & Plasma Components Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Products (Packed Red Blood Cells, Platelets Products, Frozen Plasma, Plasma Derived Products)
9.2.1.1. By Plasma Derived Products (Immunoglobulins, Albumins, Coagulation Factor Concentrates, Others)
9.2.2. By Application (Hematology, Solid Tumor Management, Others)
9.2.2.1. By Hematology (Hemoglobinopathy, Hematologic Malignancies Treatment, Coagulopathy, Others)
9.2.3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
9.2.4. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Blood & Plasma Components Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Products
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. India Blood & Plasma Components Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Products
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. Japan Blood & Plasma Components Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Products
9.3.3.2.2. By Application
9.3.3.2.3. By End User
9.3.4. South Korea Blood & Plasma Components Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Products
9.3.4.2.2. By Application
9.3.4.2.3. By End User
9.3.5. Australia Blood & Plasma Components Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Products
9.3.5.2.2. By Application
9.3.5.2.3. By End User
10. South America Blood & Plasma Components Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Products (Packed Red Blood Cells, Platelets Products, Frozen Plasma, Plasma Derived Products)
10.2.1.1. By Plasma Derived Products (Immunoglobulins, Albumins, Coagulation Factor Concentrates, Others)
10.2.2. By Application (Hematology, Solid Tumor Management, Others)
10.2.2.1. By Hematology (Hemoglobinopathy, Hematologic Malignancies Treatment, Coagulopathy, Others)
10.2.3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Blood & Plasma Components Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Products
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. Argentina Blood & Plasma Components Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Products
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. Colombia Blood & Plasma Components Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Products
10.3.3.2.2. By Application
10.3.3.2.3. By End User
11. Middle East and Africa Blood & Plasma Components Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Products (Packed Red Blood Cells, Platelets Products, Frozen Plasma, Plasma Derived Products)
11.2.1.1. By Plasma Derived Products (Immunoglobulins, Albumins, Coagulation Factor Concentrates, Others)
11.2.2. By Application (Hematology, Solid Tumor Management, Others)
11.2.2.1. By Hematology (Hemoglobinopathy, Hematologic Malignancies Treatment, Coagulopathy, Others)
11.2.3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
11.2.4. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Blood & Plasma Components Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Products
11.3.1.2.2. By Application
11.3.1.2.3. By End User
11.3.2. Saudi Arabia Blood & Plasma Components Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Products
11.3.2.2.2. By Application
11.3.2.2.3. By End User
11.3.3. UAE Blood & Plasma Components Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Products
11.3.3.2.2. By Application
11.3.3.2.3. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. CSL Limited
14.2. Grifols S.A.
14.3. ADMA Biologics, Inc.
14.4. Takeda Pharmaceutical Company Limited
14.5. Octapharma AG
14.6. Kedrion S.p.A
14.7. Emergent BioSolutions Inc.
14.8. Bio Products Laboratory Ltd.
14.9. LFB S.A.
14.10. Versiti, Inc.
15. Strategic Recommendations

 

ページTOPに戻る


 

Summary

The global blood & plasma components market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include the growing volume of surgeries, the surge in the prevalence of trauma and road accidents, and the increase in the number of people from chronic conditions, including cancer are curbing the growth of the market. Blood is a life-sustaining fluid that flows throughout the body, giving nourishment, electrolytes, hormones, antibodies, and vitamins to body tissues. Plasma is a part of the blood which is aqueous in nature; it contains salt and proteins in which platelets, white blood cells, and red blood cells are suspended. The other factors supporting the market’s growth are, rising awareness associated with the significance of blood donations, high patient pool, government initiatives, increasing investments for research and development activities, several blood donation campaigns undertaken by various blood organizations, rise in the elderly population base, rise in R&D activities, and technological advancements. Also, the strategic initiatives such as partnerships and product launches undertaken by the market players are augmenting the growth of the market.
Increasing Occurrence of Trauma and Road Accidents
The growing incidence of trauma and road accidents is a significant factor propelling the growth of the market. At times, people suffer from traumas such as hemorrhage; the amount of blood present gets reduced and cannot be replaced fast enough by the body. According to a review, in 2018, approximately 60,000 Americans died from hemorrhaging or blood loss every year. Also, owing to the rise in the number of road accidents, excessive blood loss from the body is raising the demand for blood or plasma transfusion to prevent bleeding. Thus, in turn, these situations are augmenting the growth of the blood and plasma component market globally. According to WHO research, in 2020, nearly 1.5 million people died every year due to road traffic injuries around the globe.
Rising Frequency of Blood Diseases and Surgeries
The growing incidences of bleeding disorders and the rising number of surgeries across the globe are bolstering the growth of the market. Hemophilia A and B and von Willebrand disease are the most common bleeding disorders. For instance, in 2019, 195,263 people globally were diagnosed with hemophilia, and 80,302 were diagnosed with von Willebrand disease. In addition to these, increasing cases of surgeries are impelling the growth of the market as a lot of blood is lost during the operations, which increases the chances of needing transfusions. Also, the demand for blood transfusion rises in patients who are anemic. For instance, approximately 310 million major surgeries are performed every year globally, of which 50 million are in the USA, and 20 million are in Europe.
Increasing Adoption of Inorganic Growth Strategies
Various inorganic growth strategies such as mergers, collaborations, acquisitions, and partnerships are supporting the growth of the market. For instance, the Blood Center of Wisconsin collaborated with SysLogic Inc. to research how RFID technology can be utilized to heighten the safety of the patient while collecting and transfusing blood products. Similarly, in 2018, Invitrx Inc. launched a cord blood plasma product that contains plasticity-promoting proteins that may have anti-aging effects that increase neurogenesis and cognitive function.
Market Segmentation
The global blood & plasma components market is segmented into products, applications, end user, and company. Based on products, the market is divided into packed red blood cells, platelets products, frozen plasma, and plasma-derived products. Based on plasma-derived products, the market is further divided into immunoglobulins, albumins, coagulation factor concentrates, and others. Based on application, the market is divided into hematology, solid tumor management, and others. Based on hematology, the market is further divided into hemoglobinopathy, hematologic malignancies treatment, coagulopathy, and others. Based on end-user, the market is divided into hospitals & clinics, diagnostic laboratories, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising number of chronic diseases and surgeries in the country.
Market Players
CSL Limited, Grifols S.A., ADMA Biologics, Inc., Takeda Pharmaceutical Company Limited, Octapharma AG, Kedrion S.p.A, Emergent BioSolutions Inc., Bio Products Laboratory Ltd., LFB S.A., and Versiti, Inc. are some of the leading companies operating in the market.
Report Scope:
In this report, global blood & plasma components market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Blood & Plasma Components Market, By Products:
o Packed Red Blood Cells
o Platelets Products
o Frozen Plasma
o Plasma Derived Products
 Immunoglobulins
 Albumins
 Coagulation Factor Concentrates
 Others
• Blood & Plasma Components Market, By Application:
o Hematology
 Hemoglobinopathy
 Hematologic Malignancies Treatment
 Coagulopathy
 Others
o Solid Tumor Management
o Others
• Blood & Plasma Components Market, By End User:
o Hospitals & Clinics
o Diagnostic Laboratories
o Others
• Blood & Plasma Components Market, By Region:
o North America
 United States
 Canada
 Mexico
o Asia-Pacific
 China
 India
 Japan
 Australia
 South Korea
o Europe & CIS
 Germany
 France
 United Kingdom
 Spain
 Italy
o South America
 Brazil
 Argentina
 Colombia
o Middle East & Africa
 South Africa
 Saudi Arabia
 UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Global Blood & Plasma Components Market
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).



ページTOPに戻る


Table of Contents

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Blood & Plasma Components Market
5. Voice of Customer
6. Global Blood & Plasma Components Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Products (Packed Red Blood Cells, Platelets Products, Frozen Plasma, Plasma Derived Products)
6.2.1.1. By Plasma Derived Products (Immunoglobulins, Albumins, Coagulation Factor Concentrates, Others)
6.2.2. By Application (Hematology, Solid Tumor Management, Others)
6.2.2.1. By Hematology (Hemoglobinopathy, Hematologic Malignancies Treatment, Coagulopathy, Others)
6.2.3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
6.2.4. By Company (2021)
6.2.5. By Region
6.3. Market Map
7. North America Blood & Plasma Components Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Products (Packed Red Blood Cells, Platelets Products, Frozen Plasma, Plasma Derived Products)
7.2.1.1. By Plasma Derived Products (Immunoglobulins, Albumins, Coagulation Factor Concentrates, Others)
7.2.2. By Application (Hematology, Solid Tumor Management, Others)
7.2.2.1. By Hematology (Hemoglobinopathy, Hematologic Malignancies Treatment, Coagulopathy, Others)
7.2.3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Blood & Plasma Components Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Products
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.2. Canada Blood & Plasma Components Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Products
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. Mexico Blood & Plasma Components Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Products
7.3.3.2.2. By Application
7.3.3.2.3. By End User
8. Europe Blood & Plasma Components Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Products (Packed Red Blood Cells, Platelets Products, Frozen Plasma, Plasma Derived Products)
8.2.1.1. By Plasma Derived Products (Immunoglobulins, Albumins, Coagulation Factor Concentrates, Others)
8.2.2. By Application (Hematology, Solid Tumor Management, Others)
8.2.2.1. By Hematology (Hemoglobinopathy, Hematologic Malignancies Treatment, Coagulopathy, Others)
8.2.3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. France Blood & Plasma Components Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Products
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. Germany Blood & Plasma Components Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Products
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. United Kingdom Blood & Plasma Components Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Products
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. Italy Blood & Plasma Components Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Products
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Spain Blood & Plasma Components Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Products
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. Asia-Pacific Blood & Plasma Components Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Products (Packed Red Blood Cells, Platelets Products, Frozen Plasma, Plasma Derived Products)
9.2.1.1. By Plasma Derived Products (Immunoglobulins, Albumins, Coagulation Factor Concentrates, Others)
9.2.2. By Application (Hematology, Solid Tumor Management, Others)
9.2.2.1. By Hematology (Hemoglobinopathy, Hematologic Malignancies Treatment, Coagulopathy, Others)
9.2.3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
9.2.4. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Blood & Plasma Components Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Products
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. India Blood & Plasma Components Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Products
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. Japan Blood & Plasma Components Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Products
9.3.3.2.2. By Application
9.3.3.2.3. By End User
9.3.4. South Korea Blood & Plasma Components Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Products
9.3.4.2.2. By Application
9.3.4.2.3. By End User
9.3.5. Australia Blood & Plasma Components Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Products
9.3.5.2.2. By Application
9.3.5.2.3. By End User
10. South America Blood & Plasma Components Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Products (Packed Red Blood Cells, Platelets Products, Frozen Plasma, Plasma Derived Products)
10.2.1.1. By Plasma Derived Products (Immunoglobulins, Albumins, Coagulation Factor Concentrates, Others)
10.2.2. By Application (Hematology, Solid Tumor Management, Others)
10.2.2.1. By Hematology (Hemoglobinopathy, Hematologic Malignancies Treatment, Coagulopathy, Others)
10.2.3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Blood & Plasma Components Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Products
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. Argentina Blood & Plasma Components Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Products
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. Colombia Blood & Plasma Components Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Products
10.3.3.2.2. By Application
10.3.3.2.3. By End User
11. Middle East and Africa Blood & Plasma Components Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Products (Packed Red Blood Cells, Platelets Products, Frozen Plasma, Plasma Derived Products)
11.2.1.1. By Plasma Derived Products (Immunoglobulins, Albumins, Coagulation Factor Concentrates, Others)
11.2.2. By Application (Hematology, Solid Tumor Management, Others)
11.2.2.1. By Hematology (Hemoglobinopathy, Hematologic Malignancies Treatment, Coagulopathy, Others)
11.2.3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
11.2.4. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Blood & Plasma Components Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Products
11.3.1.2.2. By Application
11.3.1.2.3. By End User
11.3.2. Saudi Arabia Blood & Plasma Components Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Products
11.3.2.2.2. By Application
11.3.2.2.3. By End User
11.3.3. UAE Blood & Plasma Components Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Products
11.3.3.2.2. By Application
11.3.3.2.3. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. CSL Limited
14.2. Grifols S.A.
14.3. ADMA Biologics, Inc.
14.4. Takeda Pharmaceutical Company Limited
14.5. Octapharma AG
14.6. Kedrion S.p.A
14.7. Emergent BioSolutions Inc.
14.8. Bio Products Laboratory Ltd.
14.9. LFB S.A.
14.10. Versiti, Inc.
15. Strategic Recommendations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

TechSci Research 社の最新刊レポート

本レポートと同じKEY WORD(clinics)の最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/07/12 10:27

160.11 円

174.44 円

209.47 円

ページTOPに戻る